Vertex Pharmaceuticals (VRTX) announced data from a Phase 4 study of JOURNAVX, a prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, in adults, that ...

By Dr. Liji Thomas, MD By merging voice instability, gait asymmetry, and tremor-driven handwriting changes into a single explainable AI framework, researchers show how digital biomarkers can move ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...

In a systematic review and meta-analysis published in the journal Molecular Psychiatry, scientists have analyzed recent evidence on the usefulness of single and multimodal neuroimaging techniques in ...

AI can process diverse data sources—ranging from medical images to genetic information to patient voice recordings—to help doctors make more informed decisions. While processing this data individually ...

Effective Patient Triaging: Prospective clinical data demonstrated a significant reduction in recall rates for low-risk cases, decreasing from 7.6% to 5.7%, which minimizes nonessential follow-up ...

Yoga vs. behavioral placebo for fatigue and quality of life among older cancer survivors. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full ...